nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—CYP3A4—prostate cancer	0.0745	1	CbGaD
Vinorelbine—TUBB2A—Cabazitaxel—prostate cancer	0.0527	0.0798	CbGbCtD
Vinorelbine—TUBB8—Cabazitaxel—prostate cancer	0.0527	0.0798	CbGbCtD
Vinorelbine—TUBB6—Cabazitaxel—prostate cancer	0.0527	0.0798	CbGbCtD
Vinorelbine—TUBB4A—Cabazitaxel—prostate cancer	0.0527	0.0798	CbGbCtD
Vinorelbine—TUBB3—Cabazitaxel—prostate cancer	0.0527	0.0798	CbGbCtD
Vinorelbine—TUBB2B—Cabazitaxel—prostate cancer	0.0527	0.0798	CbGbCtD
Vinorelbine—TUBB1—Cabazitaxel—prostate cancer	0.0441	0.0667	CbGbCtD
Vinorelbine—TUBB4B—Cabazitaxel—prostate cancer	0.0441	0.0667	CbGbCtD
Vinorelbine—TUBB—Cabazitaxel—prostate cancer	0.0441	0.0667	CbGbCtD
Vinorelbine—TUBB4A—Docetaxel—prostate cancer	0.0177	0.0268	CbGbCtD
Vinorelbine—TUBB2A—Docetaxel—prostate cancer	0.0177	0.0268	CbGbCtD
Vinorelbine—TUBB3—Docetaxel—prostate cancer	0.0177	0.0268	CbGbCtD
Vinorelbine—TUBB2B—Docetaxel—prostate cancer	0.0177	0.0268	CbGbCtD
Vinorelbine—TUBB6—Docetaxel—prostate cancer	0.0177	0.0268	CbGbCtD
Vinorelbine—TUBB8—Docetaxel—prostate cancer	0.0177	0.0268	CbGbCtD
Vinorelbine—TUBB4B—Docetaxel—prostate cancer	0.0148	0.0224	CbGbCtD
Vinorelbine—TUBB1—Docetaxel—prostate cancer	0.0148	0.0224	CbGbCtD
Vinorelbine—TUBB—Docetaxel—prostate cancer	0.0148	0.0224	CbGbCtD
Vinorelbine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00584	0.00884	CbGbCtD
Vinorelbine—CYP2D6—Bicalutamide—prostate cancer	0.00483	0.0073	CbGbCtD
Vinorelbine—ABCB1—Estramustine—prostate cancer	0.00476	0.00721	CbGbCtD
Vinorelbine—CYP2D6—Abiraterone—prostate cancer	0.004	0.00605	CbGbCtD
Vinorelbine—ABCB1—Cabazitaxel—prostate cancer	0.00314	0.00475	CbGbCtD
Vinorelbine—CYP3A4—Bicalutamide—prostate cancer	0.00307	0.00464	CbGbCtD
Vinorelbine—ABCB1—Estrone—prostate cancer	0.00307	0.00464	CbGbCtD
Vinorelbine—CYP3A4—Estramustine—prostate cancer	0.00285	0.00432	CbGbCtD
Vinorelbine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00274	0.00414	CbGbCtD
Vinorelbine—CYP3A4—Abiraterone—prostate cancer	0.00254	0.00385	CbGbCtD
Vinorelbine—CYP3A4—Flutamide—prostate cancer	0.00254	0.00385	CbGbCtD
Vinorelbine—ABCB1—Conjugated Estrogens—prostate cancer	0.00201	0.00304	CbGbCtD
Vinorelbine—CYP3A4—Cabazitaxel—prostate cancer	0.00188	0.00285	CbGbCtD
Vinorelbine—CYP3A4—Estrone—prostate cancer	0.00184	0.00278	CbGbCtD
Vinorelbine—ABCB1—Mitoxantrone—prostate cancer	0.00183	0.00276	CbGbCtD
Vinorelbine—ABCB1—Estradiol—prostate cancer	0.00176	0.00267	CbGbCtD
Vinorelbine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00164	0.00248	CbGbCtD
Vinorelbine—ABCB1—Prednisone—prostate cancer	0.00152	0.00229	CbGbCtD
Vinorelbine—TUBB8—testis—prostate cancer	0.0014	0.0376	CbGeAlD
Vinorelbine—TUBB4A—prostate gland—prostate cancer	0.00132	0.0355	CbGeAlD
Vinorelbine—TUBB2B—prostate gland—prostate cancer	0.00128	0.0343	CbGeAlD
Vinorelbine—TUBB—prostate gland—prostate cancer	0.00121	0.0324	CbGeAlD
Vinorelbine—TUBB2A—prostate gland—prostate cancer	0.0012	0.0323	CbGeAlD
Vinorelbine—CYP3A4—Conjugated Estrogens—prostate cancer	0.0012	0.00182	CbGbCtD
Vinorelbine—TUBB6—prostate gland—prostate cancer	0.00119	0.0318	CbGeAlD
Vinorelbine—CYP3A4—urine—prostate cancer	0.00118	0.0317	CbGeAlD
Vinorelbine—CYP2D6—urine—prostate cancer	0.00116	0.0312	CbGeAlD
Vinorelbine—ABCB1—Etoposide—prostate cancer	0.00115	0.00174	CbGbCtD
Vinorelbine—TUBB1—bone marrow—prostate cancer	0.0011	0.0294	CbGeAlD
Vinorelbine—CYP3A4—Mitoxantrone—prostate cancer	0.00109	0.00165	CbGbCtD
Vinorelbine—Vincristine—RALBP1—prostate cancer	0.00108	0.437	CrCbGaD
Vinorelbine—TUBB2B—seminal vesicle—prostate cancer	0.00108	0.029	CbGeAlD
Vinorelbine—CYP3A4—Estradiol—prostate cancer	0.00106	0.0016	CbGbCtD
Vinorelbine—ABCB1—Docetaxel—prostate cancer	0.00105	0.00159	CbGbCtD
Vinorelbine—TUBB4B—prostate gland—prostate cancer	0.00103	0.0277	CbGeAlD
Vinorelbine—TUBB—seminal vesicle—prostate cancer	0.00102	0.0274	CbGeAlD
Vinorelbine—TUBB2A—seminal vesicle—prostate cancer	0.00102	0.0273	CbGeAlD
Vinorelbine—TUBB6—seminal vesicle—prostate cancer	0.001	0.0269	CbGeAlD
Vinorelbine—TUBB3—testis—prostate cancer	0.000958	0.0257	CbGeAlD
Vinorelbine—TUBB1—testis—prostate cancer	0.000937	0.0251	CbGeAlD
Vinorelbine—CYP3A4—Prednisone—prostate cancer	0.000908	0.00137	CbGbCtD
Vinorelbine—TUBB4A—renal system—prostate cancer	0.000902	0.0242	CbGeAlD
Vinorelbine—TUBB4B—seminal vesicle—prostate cancer	0.000873	0.0234	CbGeAlD
Vinorelbine—TUBB6—epithelium—prostate cancer	0.000873	0.0234	CbGeAlD
Vinorelbine—TUBB2B—renal system—prostate cancer	0.000872	0.0234	CbGeAlD
Vinorelbine—TUBB2B—urethra—prostate cancer	0.000857	0.023	CbGeAlD
Vinorelbine—TUBB—urethra—prostate cancer	0.000811	0.0217	CbGeAlD
Vinorelbine—TUBB6—renal system—prostate cancer	0.00081	0.0217	CbGeAlD
Vinorelbine—TUBB2A—urethra—prostate cancer	0.000806	0.0216	CbGeAlD
Vinorelbine—TUBB6—urethra—prostate cancer	0.000795	0.0213	CbGeAlD
Vinorelbine—ABCB1—Doxorubicin—prostate cancer	0.000785	0.00119	CbGbCtD
Vinorelbine—CYP2D6—Doxorubicin—prostate cancer	0.00074	0.00112	CbGbCtD
Vinorelbine—TUBB4B—renal system—prostate cancer	0.000704	0.0189	CbGeAlD
Vinorelbine—TUBB4B—urethra—prostate cancer	0.000691	0.0185	CbGeAlD
Vinorelbine—CYP3A4—Etoposide—prostate cancer	0.00069	0.00104	CbGbCtD
Vinorelbine—CYP3A4—Docetaxel—prostate cancer	0.000631	0.000955	CbGbCtD
Vinorelbine—TUBB—bone marrow—prostate cancer	0.000624	0.0167	CbGeAlD
Vinorelbine—TUBB2A—bone marrow—prostate cancer	0.000621	0.0166	CbGeAlD
Vinorelbine—TUBB6—bone marrow—prostate cancer	0.000612	0.0164	CbGeAlD
Vinorelbine—TUBB4A—testis—prostate cancer	0.000583	0.0156	CbGeAlD
Vinorelbine—TUBB6—Fulvestrant—Estradiol—prostate cancer	0.000577	0.395	CbGdCrCtD
Vinorelbine—TUBB2B—testis—prostate cancer	0.000564	0.0151	CbGeAlD
Vinorelbine—TUBB—testis—prostate cancer	0.000533	0.0143	CbGeAlD
Vinorelbine—TUBB4B—bone marrow—prostate cancer	0.000532	0.0143	CbGeAlD
Vinorelbine—TUBB2A—testis—prostate cancer	0.000531	0.0142	CbGeAlD
Vinorelbine—TUBB6—testis—prostate cancer	0.000523	0.014	CbGeAlD
Vinorelbine—Vincristine—SLC22A3—prostate cancer	0.000505	0.204	CrCbGaD
Vinorelbine—TUBB6—Levorphanol—Estrone—prostate cancer	0.000503	0.344	CbGdCrCtD
Vinorelbine—CYP3A4—Doxorubicin—prostate cancer	0.00047	0.000712	CbGbCtD
Vinorelbine—TUBB4B—testis—prostate cancer	0.000455	0.0122	CbGeAlD
Vinorelbine—TUBB4A—lymph node—prostate cancer	0.000423	0.0113	CbGeAlD
Vinorelbine—TUBB2B—lymph node—prostate cancer	0.000409	0.0109	CbGeAlD
Vinorelbine—TUBB—lymph node—prostate cancer	0.000387	0.0104	CbGeAlD
Vinorelbine—TUBB2A—lymph node—prostate cancer	0.000385	0.0103	CbGeAlD
Vinorelbine—TUBB6—Levorphanol—Estradiol—prostate cancer	0.000381	0.261	CbGdCrCtD
Vinorelbine—TUBB6—lymph node—prostate cancer	0.000379	0.0102	CbGeAlD
Vinorelbine—Vindesine—CYP3A4—prostate cancer	0.000342	0.138	CrCbGaD
Vinorelbine—TUBB4B—lymph node—prostate cancer	0.00033	0.00884	CbGeAlD
Vinorelbine—ABCB1—prostate gland—prostate cancer	0.0003	0.00805	CbGeAlD
Vinorelbine—Vincristine—CYP3A5—prostate cancer	0.000292	0.118	CrCbGaD
Vinorelbine—CYP3A4—renal system—prostate cancer	0.000289	0.00775	CbGeAlD
Vinorelbine—CYP2D6—renal system—prostate cancer	0.000285	0.00763	CbGeAlD
Vinorelbine—ABCB1—seminal vesicle—prostate cancer	0.000254	0.00681	CbGeAlD
Vinorelbine—ABCB1—epithelium—prostate cancer	0.000221	0.00591	CbGeAlD
Vinorelbine—ABCB1—renal system—prostate cancer	0.000205	0.00549	CbGeAlD
Vinorelbine—ABCB1—urethra—prostate cancer	0.000201	0.00539	CbGeAlD
Vinorelbine—CYP2D6—testis—prostate cancer	0.000184	0.00493	CbGeAlD
Vinorelbine—ABCB1—bone marrow—prostate cancer	0.000155	0.00415	CbGeAlD
Vinorelbine—ABCB1—testis—prostate cancer	0.000132	0.00355	CbGeAlD
Vinorelbine—Vinblastine—CYP3A4—prostate cancer	0.000129	0.0519	CrCbGaD
Vinorelbine—Vincristine—CYP3A4—prostate cancer	0.000127	0.051	CrCbGaD
Vinorelbine—ABCB1—lymph node—prostate cancer	9.59e-05	0.00257	CbGeAlD
Vinorelbine—Hypertension—Capecitabine—prostate cancer	3.57e-05	0.000249	CcSEcCtD
Vinorelbine—Myalgia—Capecitabine—prostate cancer	3.52e-05	0.000246	CcSEcCtD
Vinorelbine—Chest pain—Capecitabine—prostate cancer	3.52e-05	0.000246	CcSEcCtD
Vinorelbine—Arthralgia—Capecitabine—prostate cancer	3.52e-05	0.000246	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	3.5e-05	0.000244	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Epirubicin—prostate cancer	3.49e-05	0.000243	CcSEcCtD
Vinorelbine—Anaphylactic shock—Docetaxel—prostate cancer	3.49e-05	0.000243	CcSEcCtD
Vinorelbine—Discomfort—Capecitabine—prostate cancer	3.48e-05	0.000243	CcSEcCtD
Vinorelbine—Infection—Docetaxel—prostate cancer	3.46e-05	0.000242	CcSEcCtD
Vinorelbine—Weight decreased—Doxorubicin—prostate cancer	3.46e-05	0.000241	CcSEcCtD
Vinorelbine—Feeling abnormal—Etoposide—prostate cancer	3.46e-05	0.000241	CcSEcCtD
Vinorelbine—Diarrhoea—Mitoxantrone—prostate cancer	3.45e-05	0.000241	CcSEcCtD
Vinorelbine—Vomiting—Estradiol—prostate cancer	3.44e-05	0.00024	CcSEcCtD
Vinorelbine—Agranulocytosis—Epirubicin—prostate cancer	3.44e-05	0.00024	CcSEcCtD
Vinorelbine—Pneumonia—Doxorubicin—prostate cancer	3.43e-05	0.000239	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Etoposide—prostate cancer	3.43e-05	0.000239	CcSEcCtD
Vinorelbine—Nervous system disorder—Docetaxel—prostate cancer	3.42e-05	0.000239	CcSEcCtD
Vinorelbine—Ill-defined disorder—Prednisone—prostate cancer	3.42e-05	0.000238	CcSEcCtD
Vinorelbine—Thrombocytopenia—Docetaxel—prostate cancer	3.41e-05	0.000238	CcSEcCtD
Vinorelbine—Rash—Estradiol—prostate cancer	3.41e-05	0.000238	CcSEcCtD
Vinorelbine—Infestation NOS—Doxorubicin—prostate cancer	3.41e-05	0.000238	CcSEcCtD
Vinorelbine—Infestation—Doxorubicin—prostate cancer	3.41e-05	0.000238	CcSEcCtD
Vinorelbine—Dermatitis—Estradiol—prostate cancer	3.41e-05	0.000238	CcSEcCtD
Vinorelbine—Anaemia—Prednisone—prostate cancer	3.41e-05	0.000238	CcSEcCtD
Vinorelbine—Tachycardia—Docetaxel—prostate cancer	3.4e-05	0.000237	CcSEcCtD
Vinorelbine—Headache—Estradiol—prostate cancer	3.39e-05	0.000237	CcSEcCtD
Vinorelbine—Skin disorder—Docetaxel—prostate cancer	3.39e-05	0.000236	CcSEcCtD
Vinorelbine—Angioedema—Prednisone—prostate cancer	3.37e-05	0.000235	CcSEcCtD
Vinorelbine—Infection—Capecitabine—prostate cancer	3.35e-05	0.000234	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Doxorubicin—prostate cancer	3.34e-05	0.000233	CcSEcCtD
Vinorelbine—Urticaria—Etoposide—prostate cancer	3.33e-05	0.000232	CcSEcCtD
Vinorelbine—Stomatitis—Doxorubicin—prostate cancer	3.33e-05	0.000232	CcSEcCtD
Vinorelbine—Anorexia—Docetaxel—prostate cancer	3.32e-05	0.000232	CcSEcCtD
Vinorelbine—Malaise—Prednisone—prostate cancer	3.32e-05	0.000232	CcSEcCtD
Vinorelbine—Abdominal pain—Etoposide—prostate cancer	3.32e-05	0.000231	CcSEcCtD
Vinorelbine—Body temperature increased—Etoposide—prostate cancer	3.32e-05	0.000231	CcSEcCtD
Vinorelbine—Nervous system disorder—Capecitabine—prostate cancer	3.31e-05	0.000231	CcSEcCtD
Vinorelbine—Vertigo—Prednisone—prostate cancer	3.31e-05	0.000231	CcSEcCtD
Vinorelbine—Thrombocytopenia—Capecitabine—prostate cancer	3.31e-05	0.000231	CcSEcCtD
Vinorelbine—Tachycardia—Capecitabine—prostate cancer	3.29e-05	0.00023	CcSEcCtD
Vinorelbine—Hypoaesthesia—Epirubicin—prostate cancer	3.29e-05	0.00023	CcSEcCtD
Vinorelbine—Skin disorder—Capecitabine—prostate cancer	3.28e-05	0.000229	CcSEcCtD
Vinorelbine—Hypotension—Docetaxel—prostate cancer	3.26e-05	0.000227	CcSEcCtD
Vinorelbine—Connective tissue disorder—Epirubicin—prostate cancer	3.25e-05	0.000227	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Doxorubicin—prostate cancer	3.23e-05	0.000225	CcSEcCtD
Vinorelbine—Anorexia—Capecitabine—prostate cancer	3.22e-05	0.000224	CcSEcCtD
Vinorelbine—Nausea—Estradiol—prostate cancer	3.22e-05	0.000224	CcSEcCtD
Vinorelbine—Vomiting—Mitoxantrone—prostate cancer	3.21e-05	0.000224	CcSEcCtD
Vinorelbine—Agranulocytosis—Doxorubicin—prostate cancer	3.18e-05	0.000222	CcSEcCtD
Vinorelbine—Hypertension—Prednisone—prostate cancer	3.18e-05	0.000222	CcSEcCtD
Vinorelbine—Rash—Mitoxantrone—prostate cancer	3.18e-05	0.000222	CcSEcCtD
Vinorelbine—Dermatitis—Mitoxantrone—prostate cancer	3.18e-05	0.000222	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.18e-05	0.000222	CcSEcCtD
Vinorelbine—Headache—Mitoxantrone—prostate cancer	3.16e-05	0.00022	CcSEcCtD
Vinorelbine—Hypotension—Capecitabine—prostate cancer	3.15e-05	0.00022	CcSEcCtD
Vinorelbine—Arthralgia—Prednisone—prostate cancer	3.14e-05	0.000219	CcSEcCtD
Vinorelbine—Myalgia—Prednisone—prostate cancer	3.14e-05	0.000219	CcSEcCtD
Vinorelbine—Paraesthesia—Docetaxel—prostate cancer	3.13e-05	0.000218	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.12e-05	0.000217	CcSEcCtD
Vinorelbine—Dyspnoea—Docetaxel—prostate cancer	3.11e-05	0.000217	CcSEcCtD
Vinorelbine—Discomfort—Prednisone—prostate cancer	3.1e-05	0.000216	CcSEcCtD
Vinorelbine—Hypersensitivity—Etoposide—prostate cancer	3.09e-05	0.000216	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.08e-05	0.000215	CcSEcCtD
Vinorelbine—Cardiac disorder—Epirubicin—prostate cancer	3.07e-05	0.000214	CcSEcCtD
Vinorelbine—Flushing—Epirubicin—prostate cancer	3.07e-05	0.000214	CcSEcCtD
Vinorelbine—Hypoaesthesia—Doxorubicin—prostate cancer	3.05e-05	0.000213	CcSEcCtD
Vinorelbine—Paraesthesia—Capecitabine—prostate cancer	3.03e-05	0.000211	CcSEcCtD
Vinorelbine—Decreased appetite—Docetaxel—prostate cancer	3.03e-05	0.000211	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Docetaxel—prostate cancer	3.01e-05	0.00021	CcSEcCtD
Vinorelbine—Asthenia—Etoposide—prostate cancer	3.01e-05	0.00021	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—prostate cancer	3.01e-05	0.00021	CcSEcCtD
Vinorelbine—Dyspnoea—Capecitabine—prostate cancer	3.01e-05	0.00021	CcSEcCtD
Vinorelbine—Anaphylactic shock—Prednisone—prostate cancer	3.01e-05	0.00021	CcSEcCtD
Vinorelbine—Fatigue—Docetaxel—prostate cancer	3.01e-05	0.00021	CcSEcCtD
Vinorelbine—Angiopathy—Epirubicin—prostate cancer	3e-05	0.00021	CcSEcCtD
Vinorelbine—Nausea—Mitoxantrone—prostate cancer	3e-05	0.000209	CcSEcCtD
Vinorelbine—Immune system disorder—Epirubicin—prostate cancer	2.99e-05	0.000209	CcSEcCtD
Vinorelbine—Infection—Prednisone—prostate cancer	2.99e-05	0.000208	CcSEcCtD
Vinorelbine—Mediastinal disorder—Epirubicin—prostate cancer	2.98e-05	0.000208	CcSEcCtD
Vinorelbine—Pain—Docetaxel—prostate cancer	2.98e-05	0.000208	CcSEcCtD
Vinorelbine—Constipation—Docetaxel—prostate cancer	2.98e-05	0.000208	CcSEcCtD
Vinorelbine—Pruritus—Etoposide—prostate cancer	2.97e-05	0.000207	CcSEcCtD
Vinorelbine—Arrhythmia—Epirubicin—prostate cancer	2.96e-05	0.000206	CcSEcCtD
Vinorelbine—Nervous system disorder—Prednisone—prostate cancer	2.95e-05	0.000206	CcSEcCtD
Vinorelbine—Tachycardia—Prednisone—prostate cancer	2.93e-05	0.000205	CcSEcCtD
Vinorelbine—Decreased appetite—Capecitabine—prostate cancer	2.93e-05	0.000205	CcSEcCtD
Vinorelbine—Alopecia—Epirubicin—prostate cancer	2.93e-05	0.000204	CcSEcCtD
Vinorelbine—Skin disorder—Prednisone—prostate cancer	2.92e-05	0.000204	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Capecitabine—prostate cancer	2.91e-05	0.000203	CcSEcCtD
Vinorelbine—Fatigue—Capecitabine—prostate cancer	2.91e-05	0.000203	CcSEcCtD
Vinorelbine—Constipation—Capecitabine—prostate cancer	2.89e-05	0.000201	CcSEcCtD
Vinorelbine—Pain—Capecitabine—prostate cancer	2.89e-05	0.000201	CcSEcCtD
Vinorelbine—Malnutrition—Epirubicin—prostate cancer	2.88e-05	0.000201	CcSEcCtD
Vinorelbine—Erythema—Epirubicin—prostate cancer	2.88e-05	0.000201	CcSEcCtD
Vinorelbine—Feeling abnormal—Docetaxel—prostate cancer	2.87e-05	0.0002	CcSEcCtD
Vinorelbine—Diarrhoea—Etoposide—prostate cancer	2.87e-05	0.0002	CcSEcCtD
Vinorelbine—Anorexia—Prednisone—prostate cancer	2.87e-05	0.0002	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Docetaxel—prostate cancer	2.85e-05	0.000199	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—prostate cancer	2.84e-05	0.000198	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—prostate cancer	2.84e-05	0.000198	CcSEcCtD
Vinorelbine—Back pain—Epirubicin—prostate cancer	2.79e-05	0.000194	CcSEcCtD
Vinorelbine—Feeling abnormal—Capecitabine—prostate cancer	2.78e-05	0.000194	CcSEcCtD
Vinorelbine—Angiopathy—Doxorubicin—prostate cancer	2.78e-05	0.000194	CcSEcCtD
Vinorelbine—Dizziness—Etoposide—prostate cancer	2.77e-05	0.000194	CcSEcCtD
Vinorelbine—Immune system disorder—Doxorubicin—prostate cancer	2.77e-05	0.000193	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Capecitabine—prostate cancer	2.76e-05	0.000193	CcSEcCtD
Vinorelbine—Mediastinal disorder—Doxorubicin—prostate cancer	2.76e-05	0.000193	CcSEcCtD
Vinorelbine—Abdominal pain—Docetaxel—prostate cancer	2.76e-05	0.000192	CcSEcCtD
Vinorelbine—Body temperature increased—Docetaxel—prostate cancer	2.76e-05	0.000192	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Prednisone—prostate cancer	2.74e-05	0.000191	CcSEcCtD
Vinorelbine—Arrhythmia—Doxorubicin—prostate cancer	2.74e-05	0.000191	CcSEcCtD
Vinorelbine—Alopecia—Doxorubicin—prostate cancer	2.71e-05	0.000189	CcSEcCtD
Vinorelbine—Paraesthesia—Prednisone—prostate cancer	2.7e-05	0.000188	CcSEcCtD
Vinorelbine—Urticaria—Capecitabine—prostate cancer	2.68e-05	0.000187	CcSEcCtD
Vinorelbine—Ill-defined disorder—Epirubicin—prostate cancer	2.67e-05	0.000187	CcSEcCtD
Vinorelbine—Abdominal pain—Capecitabine—prostate cancer	2.67e-05	0.000186	CcSEcCtD
Vinorelbine—Body temperature increased—Capecitabine—prostate cancer	2.67e-05	0.000186	CcSEcCtD
Vinorelbine—Vomiting—Etoposide—prostate cancer	2.67e-05	0.000186	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—prostate cancer	2.67e-05	0.000186	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—prostate cancer	2.67e-05	0.000186	CcSEcCtD
Vinorelbine—Anaemia—Epirubicin—prostate cancer	2.66e-05	0.000186	CcSEcCtD
Vinorelbine—Rash—Etoposide—prostate cancer	2.65e-05	0.000185	CcSEcCtD
Vinorelbine—Dermatitis—Etoposide—prostate cancer	2.64e-05	0.000184	CcSEcCtD
Vinorelbine—Headache—Etoposide—prostate cancer	2.63e-05	0.000183	CcSEcCtD
Vinorelbine—Decreased appetite—Prednisone—prostate cancer	2.61e-05	0.000182	CcSEcCtD
Vinorelbine—Malaise—Epirubicin—prostate cancer	2.6e-05	0.000181	CcSEcCtD
Vinorelbine—Fatigue—Prednisone—prostate cancer	2.59e-05	0.000181	CcSEcCtD
Vinorelbine—Vertigo—Epirubicin—prostate cancer	2.59e-05	0.000181	CcSEcCtD
Vinorelbine—Leukopenia—Epirubicin—prostate cancer	2.58e-05	0.00018	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—prostate cancer	2.58e-05	0.00018	CcSEcCtD
Vinorelbine—Constipation—Prednisone—prostate cancer	2.57e-05	0.000179	CcSEcCtD
Vinorelbine—Hypersensitivity—Docetaxel—prostate cancer	2.57e-05	0.000179	CcSEcCtD
Vinorelbine—Palpitations—Epirubicin—prostate cancer	2.55e-05	0.000178	CcSEcCtD
Vinorelbine—Cough—Epirubicin—prostate cancer	2.51e-05	0.000175	CcSEcCtD
Vinorelbine—Asthenia—Docetaxel—prostate cancer	2.5e-05	0.000175	CcSEcCtD
Vinorelbine—Nausea—Etoposide—prostate cancer	2.49e-05	0.000174	CcSEcCtD
Vinorelbine—Hypertension—Epirubicin—prostate cancer	2.49e-05	0.000174	CcSEcCtD
Vinorelbine—Hypersensitivity—Capecitabine—prostate cancer	2.49e-05	0.000173	CcSEcCtD
Vinorelbine—Feeling abnormal—Prednisone—prostate cancer	2.48e-05	0.000173	CcSEcCtD
Vinorelbine—Ill-defined disorder—Doxorubicin—prostate cancer	2.47e-05	0.000173	CcSEcCtD
Vinorelbine—Pruritus—Docetaxel—prostate cancer	2.47e-05	0.000172	CcSEcCtD
Vinorelbine—Anaemia—Doxorubicin—prostate cancer	2.46e-05	0.000172	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Prednisone—prostate cancer	2.46e-05	0.000172	CcSEcCtD
Vinorelbine—Arthralgia—Epirubicin—prostate cancer	2.45e-05	0.000171	CcSEcCtD
Vinorelbine—Chest pain—Epirubicin—prostate cancer	2.45e-05	0.000171	CcSEcCtD
Vinorelbine—Myalgia—Epirubicin—prostate cancer	2.45e-05	0.000171	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.44e-05	0.00017	CcSEcCtD
Vinorelbine—Discomfort—Epirubicin—prostate cancer	2.42e-05	0.000169	CcSEcCtD
Vinorelbine—Asthenia—Capecitabine—prostate cancer	2.42e-05	0.000169	CcSEcCtD
Vinorelbine—Malaise—Doxorubicin—prostate cancer	2.4e-05	0.000168	CcSEcCtD
Vinorelbine—Vertigo—Doxorubicin—prostate cancer	2.4e-05	0.000167	CcSEcCtD
Vinorelbine—Urticaria—Prednisone—prostate cancer	2.39e-05	0.000167	CcSEcCtD
Vinorelbine—Pruritus—Capecitabine—prostate cancer	2.39e-05	0.000167	CcSEcCtD
Vinorelbine—Leukopenia—Doxorubicin—prostate cancer	2.39e-05	0.000166	CcSEcCtD
Vinorelbine—Diarrhoea—Docetaxel—prostate cancer	2.39e-05	0.000166	CcSEcCtD
Vinorelbine—Body temperature increased—Prednisone—prostate cancer	2.38e-05	0.000166	CcSEcCtD
Vinorelbine—Abdominal pain—Prednisone—prostate cancer	2.38e-05	0.000166	CcSEcCtD
Vinorelbine—Palpitations—Doxorubicin—prostate cancer	2.36e-05	0.000164	CcSEcCtD
Vinorelbine—Anaphylactic shock—Epirubicin—prostate cancer	2.35e-05	0.000164	CcSEcCtD
Vinorelbine—Infection—Epirubicin—prostate cancer	2.34e-05	0.000163	CcSEcCtD
Vinorelbine—Cough—Doxorubicin—prostate cancer	2.33e-05	0.000162	CcSEcCtD
Vinorelbine—Diarrhoea—Capecitabine—prostate cancer	2.31e-05	0.000161	CcSEcCtD
Vinorelbine—Nervous system disorder—Epirubicin—prostate cancer	2.31e-05	0.000161	CcSEcCtD
Vinorelbine—Dizziness—Docetaxel—prostate cancer	2.31e-05	0.000161	CcSEcCtD
Vinorelbine—Thrombocytopenia—Epirubicin—prostate cancer	2.3e-05	0.000161	CcSEcCtD
Vinorelbine—Hypertension—Doxorubicin—prostate cancer	2.3e-05	0.000161	CcSEcCtD
Vinorelbine—Tachycardia—Epirubicin—prostate cancer	2.3e-05	0.00016	CcSEcCtD
Vinorelbine—Skin disorder—Epirubicin—prostate cancer	2.28e-05	0.000159	CcSEcCtD
Vinorelbine—Myalgia—Doxorubicin—prostate cancer	2.27e-05	0.000158	CcSEcCtD
Vinorelbine—Arthralgia—Doxorubicin—prostate cancer	2.27e-05	0.000158	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—prostate cancer	2.27e-05	0.000158	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.25e-05	0.000157	CcSEcCtD
Vinorelbine—Discomfort—Doxorubicin—prostate cancer	2.24e-05	0.000156	CcSEcCtD
Vinorelbine—Anorexia—Epirubicin—prostate cancer	2.24e-05	0.000156	CcSEcCtD
Vinorelbine—Dizziness—Capecitabine—prostate cancer	2.23e-05	0.000156	CcSEcCtD
Vinorelbine—Vomiting—Docetaxel—prostate cancer	2.22e-05	0.000155	CcSEcCtD
Vinorelbine—Hypersensitivity—Prednisone—prostate cancer	2.22e-05	0.000155	CcSEcCtD
Vinorelbine—Rash—Docetaxel—prostate cancer	2.2e-05	0.000153	CcSEcCtD
Vinorelbine—Hypotension—Epirubicin—prostate cancer	2.2e-05	0.000153	CcSEcCtD
Vinorelbine—Dermatitis—Docetaxel—prostate cancer	2.2e-05	0.000153	CcSEcCtD
Vinorelbine—Headache—Docetaxel—prostate cancer	2.18e-05	0.000152	CcSEcCtD
Vinorelbine—Anaphylactic shock—Doxorubicin—prostate cancer	2.18e-05	0.000152	CcSEcCtD
Vinorelbine—Infection—Doxorubicin—prostate cancer	2.16e-05	0.000151	CcSEcCtD
Vinorelbine—Asthenia—Prednisone—prostate cancer	2.16e-05	0.00015	CcSEcCtD
Vinorelbine—Vomiting—Capecitabine—prostate cancer	2.15e-05	0.00015	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.14e-05	0.000149	CcSEcCtD
Vinorelbine—Nervous system disorder—Doxorubicin—prostate cancer	2.13e-05	0.000149	CcSEcCtD
Vinorelbine—Thrombocytopenia—Doxorubicin—prostate cancer	2.13e-05	0.000149	CcSEcCtD
Vinorelbine—Rash—Capecitabine—prostate cancer	2.13e-05	0.000148	CcSEcCtD
Vinorelbine—Pruritus—Prednisone—prostate cancer	2.13e-05	0.000148	CcSEcCtD
Vinorelbine—Dermatitis—Capecitabine—prostate cancer	2.13e-05	0.000148	CcSEcCtD
Vinorelbine—Tachycardia—Doxorubicin—prostate cancer	2.12e-05	0.000148	CcSEcCtD
Vinorelbine—Headache—Capecitabine—prostate cancer	2.11e-05	0.000148	CcSEcCtD
Vinorelbine—Skin disorder—Doxorubicin—prostate cancer	2.11e-05	0.000147	CcSEcCtD
Vinorelbine—Paraesthesia—Epirubicin—prostate cancer	2.11e-05	0.000147	CcSEcCtD
Vinorelbine—Dyspnoea—Epirubicin—prostate cancer	2.1e-05	0.000146	CcSEcCtD
Vinorelbine—Anorexia—Doxorubicin—prostate cancer	2.07e-05	0.000145	CcSEcCtD
Vinorelbine—Nausea—Docetaxel—prostate cancer	2.07e-05	0.000144	CcSEcCtD
Vinorelbine—Diarrhoea—Prednisone—prostate cancer	2.06e-05	0.000144	CcSEcCtD
Vinorelbine—Decreased appetite—Epirubicin—prostate cancer	2.04e-05	0.000143	CcSEcCtD
Vinorelbine—Hypotension—Doxorubicin—prostate cancer	2.03e-05	0.000142	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Epirubicin—prostate cancer	2.03e-05	0.000142	CcSEcCtD
Vinorelbine—Fatigue—Epirubicin—prostate cancer	2.03e-05	0.000141	CcSEcCtD
Vinorelbine—Pain—Epirubicin—prostate cancer	2.01e-05	0.00014	CcSEcCtD
Vinorelbine—Constipation—Epirubicin—prostate cancer	2.01e-05	0.00014	CcSEcCtD
Vinorelbine—Nausea—Capecitabine—prostate cancer	2.01e-05	0.00014	CcSEcCtD
Vinorelbine—Dizziness—Prednisone—prostate cancer	1.99e-05	0.000139	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.98e-05	0.000138	CcSEcCtD
Vinorelbine—Paraesthesia—Doxorubicin—prostate cancer	1.95e-05	0.000136	CcSEcCtD
Vinorelbine—Dyspnoea—Doxorubicin—prostate cancer	1.94e-05	0.000135	CcSEcCtD
Vinorelbine—Feeling abnormal—Epirubicin—prostate cancer	1.94e-05	0.000135	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Epirubicin—prostate cancer	1.92e-05	0.000134	CcSEcCtD
Vinorelbine—Vomiting—Prednisone—prostate cancer	1.91e-05	0.000133	CcSEcCtD
Vinorelbine—Rash—Prednisone—prostate cancer	1.9e-05	0.000132	CcSEcCtD
Vinorelbine—Dermatitis—Prednisone—prostate cancer	1.89e-05	0.000132	CcSEcCtD
Vinorelbine—Decreased appetite—Doxorubicin—prostate cancer	1.89e-05	0.000132	CcSEcCtD
Vinorelbine—Headache—Prednisone—prostate cancer	1.88e-05	0.000131	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.88e-05	0.000131	CcSEcCtD
Vinorelbine—Fatigue—Doxorubicin—prostate cancer	1.88e-05	0.000131	CcSEcCtD
Vinorelbine—Urticaria—Epirubicin—prostate cancer	1.87e-05	0.00013	CcSEcCtD
Vinorelbine—Pain—Doxorubicin—prostate cancer	1.86e-05	0.00013	CcSEcCtD
Vinorelbine—Constipation—Doxorubicin—prostate cancer	1.86e-05	0.00013	CcSEcCtD
Vinorelbine—Abdominal pain—Epirubicin—prostate cancer	1.86e-05	0.00013	CcSEcCtD
Vinorelbine—Body temperature increased—Epirubicin—prostate cancer	1.86e-05	0.00013	CcSEcCtD
Vinorelbine—Feeling abnormal—Doxorubicin—prostate cancer	1.79e-05	0.000125	CcSEcCtD
Vinorelbine—Nausea—Prednisone—prostate cancer	1.79e-05	0.000125	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.78e-05	0.000124	CcSEcCtD
Vinorelbine—Hypersensitivity—Epirubicin—prostate cancer	1.73e-05	0.000121	CcSEcCtD
Vinorelbine—Urticaria—Doxorubicin—prostate cancer	1.73e-05	0.000121	CcSEcCtD
Vinorelbine—Abdominal pain—Doxorubicin—prostate cancer	1.72e-05	0.00012	CcSEcCtD
Vinorelbine—Body temperature increased—Doxorubicin—prostate cancer	1.72e-05	0.00012	CcSEcCtD
Vinorelbine—Asthenia—Epirubicin—prostate cancer	1.69e-05	0.000118	CcSEcCtD
Vinorelbine—Pruritus—Epirubicin—prostate cancer	1.66e-05	0.000116	CcSEcCtD
Vinorelbine—Diarrhoea—Epirubicin—prostate cancer	1.61e-05	0.000112	CcSEcCtD
Vinorelbine—Hypersensitivity—Doxorubicin—prostate cancer	1.6e-05	0.000112	CcSEcCtD
Vinorelbine—Asthenia—Doxorubicin—prostate cancer	1.56e-05	0.000109	CcSEcCtD
Vinorelbine—Dizziness—Epirubicin—prostate cancer	1.56e-05	0.000108	CcSEcCtD
Vinorelbine—Pruritus—Doxorubicin—prostate cancer	1.54e-05	0.000107	CcSEcCtD
Vinorelbine—Vomiting—Epirubicin—prostate cancer	1.5e-05	0.000104	CcSEcCtD
Vinorelbine—Diarrhoea—Doxorubicin—prostate cancer	1.49e-05	0.000104	CcSEcCtD
Vinorelbine—Rash—Epirubicin—prostate cancer	1.48e-05	0.000103	CcSEcCtD
Vinorelbine—Dermatitis—Epirubicin—prostate cancer	1.48e-05	0.000103	CcSEcCtD
Vinorelbine—Headache—Epirubicin—prostate cancer	1.47e-05	0.000103	CcSEcCtD
Vinorelbine—Dizziness—Doxorubicin—prostate cancer	1.44e-05	0.0001	CcSEcCtD
Vinorelbine—Nausea—Epirubicin—prostate cancer	1.4e-05	9.74e-05	CcSEcCtD
Vinorelbine—Vomiting—Doxorubicin—prostate cancer	1.38e-05	9.65e-05	CcSEcCtD
Vinorelbine—Rash—Doxorubicin—prostate cancer	1.37e-05	9.57e-05	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—prostate cancer	1.37e-05	9.56e-05	CcSEcCtD
Vinorelbine—Headache—Doxorubicin—prostate cancer	1.36e-05	9.51e-05	CcSEcCtD
Vinorelbine—Nausea—Doxorubicin—prostate cancer	1.29e-05	9.02e-05	CcSEcCtD
Vinorelbine—ABCB1—Metabolism—PHGDH—prostate cancer	4.84e-06	6.06e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—UMPS—prostate cancer	4.84e-06	6.06e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CKMT2—prostate cancer	4.82e-06	6.04e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GRHPR—prostate cancer	4.82e-06	6.04e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—UGT2B15—prostate cancer	4.82e-06	6.04e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—UGT2B17—prostate cancer	4.82e-06	6.04e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.81e-06	6.03e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	4.76e-06	5.96e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ACSL4—prostate cancer	4.75e-06	5.95e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HSD17B3—prostate cancer	4.75e-06	5.95e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—LDHB—prostate cancer	4.74e-06	5.94e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP3A5—prostate cancer	4.65e-06	5.83e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	4.63e-06	5.8e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	4.57e-06	5.73e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PHGDH—prostate cancer	4.56e-06	5.71e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ARG2—prostate cancer	4.56e-06	5.71e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—UMPS—prostate cancer	4.56e-06	5.71e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MBTPS1—prostate cancer	4.53e-06	5.68e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—RFK—prostate cancer	4.53e-06	5.68e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PGAM2—prostate cancer	4.53e-06	5.68e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NAGLU—prostate cancer	4.53e-06	5.68e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTM3—prostate cancer	4.53e-06	5.68e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SULT2B1—prostate cancer	4.53e-06	5.68e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AOX1—prostate cancer	4.53e-06	5.68e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	4.51e-06	5.65e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—UCP3—prostate cancer	4.5e-06	5.63e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PDHA1—prostate cancer	4.5e-06	5.63e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTA3—prostate cancer	4.5e-06	5.63e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TCN2—prostate cancer	4.5e-06	5.63e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—LDHB—prostate cancer	4.47e-06	5.6e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP3A5—prostate cancer	4.39e-06	5.49e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AMACR—prostate cancer	4.3e-06	5.38e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP3A43—prostate cancer	4.3e-06	5.38e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NAT1—prostate cancer	4.3e-06	5.38e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SRD5A2—prostate cancer	4.3e-06	5.38e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—DEGS1—prostate cancer	4.3e-06	5.38e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HSD3B1—prostate cancer	4.29e-06	5.37e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC22A3—prostate cancer	4.29e-06	5.37e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TCN2—prostate cancer	4.24e-06	5.31e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—UCP3—prostate cancer	4.24e-06	5.31e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PDHA1—prostate cancer	4.24e-06	5.31e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTA3—prostate cancer	4.24e-06	5.31e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	4.15e-06	5.2e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	4.14e-06	5.18e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TBXAS1—prostate cancer	4.11e-06	5.15e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTA4—prostate cancer	4.11e-06	5.15e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HSD17B1—prostate cancer	4.1e-06	5.14e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	4.06e-06	5.08e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HSD3B1—prostate cancer	4.04e-06	5.06e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC22A3—prostate cancer	4.04e-06	5.06e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTA2—prostate cancer	4.01e-06	5.02e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SULT1A1—prostate cancer	3.96e-06	4.96e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ABCG5—prostate cancer	3.96e-06	4.96e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TBXAS1—prostate cancer	3.87e-06	4.85e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTA4—prostate cancer	3.87e-06	4.85e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTA1—prostate cancer	3.87e-06	4.84e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	3.83e-06	4.8e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HSD3B2—prostate cancer	3.82e-06	4.79e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NAT2—prostate cancer	3.82e-06	4.79e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTO1—prostate cancer	3.82e-06	4.79e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTA2—prostate cancer	3.78e-06	4.73e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SULT1A1—prostate cancer	3.73e-06	4.67e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCG5—prostate cancer	3.73e-06	4.67e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PLCB2—prostate cancer	3.66e-06	4.59e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—LRP2—prostate cancer	3.66e-06	4.59e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP2C18—prostate cancer	3.66e-06	4.59e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HPGD—prostate cancer	3.65e-06	4.58e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—B4GALT4—prostate cancer	3.65e-06	4.58e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTA1—prostate cancer	3.64e-06	4.56e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTO1—prostate cancer	3.6e-06	4.51e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HSD3B2—prostate cancer	3.6e-06	4.51e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NAT2—prostate cancer	3.6e-06	4.51e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—P4HB—prostate cancer	3.59e-06	4.5e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	3.52e-06	4.41e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC22A1—prostate cancer	3.5e-06	4.38e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	3.49e-06	4.38e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PLCB2—prostate cancer	3.45e-06	4.33e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—LRP2—prostate cancer	3.45e-06	4.33e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP2C18—prostate cancer	3.45e-06	4.33e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	3.44e-06	4.3e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SULT2A1—prostate cancer	3.41e-06	4.27e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	3.41e-06	4.27e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—P4HB—prostate cancer	3.39e-06	4.24e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MED12—prostate cancer	3.35e-06	4.2e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP7B1—prostate cancer	3.34e-06	4.19e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MTAP—prostate cancer	3.34e-06	4.19e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GNG5—prostate cancer	3.32e-06	4.17e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC22A1—prostate cancer	3.29e-06	4.13e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SULT1E1—prostate cancer	3.26e-06	4.08e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SRD5A1—prostate cancer	3.26e-06	4.08e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SULT2A1—prostate cancer	3.21e-06	4.02e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NCOA3—prostate cancer	3.2e-06	4.01e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MED12—prostate cancer	3.16e-06	3.96e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GNG5—prostate cancer	3.13e-06	3.93e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.11e-06	3.89e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ACSL4—prostate cancer	3.11e-06	3.89e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HPGDS—prostate cancer	3.06e-06	3.83e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP2C19—prostate cancer	3.04e-06	3.8e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NCOA3—prostate cancer	3.02e-06	3.78e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ARG2—prostate cancer	2.98e-06	3.73e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PHGDH—prostate cancer	2.98e-06	3.73e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—UMPS—prostate cancer	2.98e-06	3.73e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ACHE—prostate cancer	2.96e-06	3.71e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTT1—prostate cancer	2.96e-06	3.71e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP2A6—prostate cancer	2.93e-06	3.67e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—LDHB—prostate cancer	2.92e-06	3.66e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HPGDS—prostate cancer	2.88e-06	3.61e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.88e-06	3.6e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.87e-06	3.59e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP2C19—prostate cancer	2.86e-06	3.58e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AKR1C3—prostate cancer	2.85e-06	3.57e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PRKACB—prostate cancer	2.83e-06	3.55e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP17A1—prostate cancer	2.81e-06	3.51e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ACHE—prostate cancer	2.79e-06	3.5e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTT1—prostate cancer	2.79e-06	3.5e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.77e-06	3.48e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PDHA1—prostate cancer	2.77e-06	3.47e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TCN2—prostate cancer	2.77e-06	3.47e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—UCP3—prostate cancer	2.77e-06	3.47e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTA3—prostate cancer	2.77e-06	3.47e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP2A6—prostate cancer	2.76e-06	3.46e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AKR1C3—prostate cancer	2.69e-06	3.36e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NCOA2—prostate cancer	2.67e-06	3.35e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PRKACB—prostate cancer	2.67e-06	3.35e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP17A1—prostate cancer	2.64e-06	3.31e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.64e-06	3.31e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.64e-06	3.31e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC5A5—prostate cancer	2.55e-06	3.19e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.53e-06	3.17e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTA4—prostate cancer	2.53e-06	3.17e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NCOA2—prostate cancer	2.52e-06	3.16e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP2E1—prostate cancer	2.49e-06	3.12e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTA2—prostate cancer	2.47e-06	3.09e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NQO1—prostate cancer	2.46e-06	3.09e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.44e-06	3.05e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCG5—prostate cancer	2.44e-06	3.05e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TH—prostate cancer	2.43e-06	3.04e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.4e-06	3.01e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP3A4—prostate cancer	2.4e-06	3.01e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTA1—prostate cancer	2.38e-06	2.98e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP1B1—prostate cancer	2.36e-06	2.96e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTO1—prostate cancer	2.35e-06	2.95e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.35e-06	2.95e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NAT2—prostate cancer	2.35e-06	2.95e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.35e-06	2.94e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NQO1—prostate cancer	2.32e-06	2.91e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TH—prostate cancer	2.29e-06	2.87e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GGT1—prostate cancer	2.29e-06	2.87e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.26e-06	2.84e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PLCB2—prostate cancer	2.26e-06	2.83e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—LRP2—prostate cancer	2.26e-06	2.83e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.26e-06	2.83e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NCOA1—prostate cancer	2.25e-06	2.82e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.23e-06	2.79e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP19A1—prostate cancer	2.22e-06	2.78e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—P4HB—prostate cancer	2.21e-06	2.77e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GGT1—prostate cancer	2.15e-06	2.7e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.15e-06	2.7e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—RXRA—prostate cancer	2.14e-06	2.68e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NCOA1—prostate cancer	2.12e-06	2.66e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.1e-06	2.63e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.09e-06	2.62e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MED12—prostate cancer	2.06e-06	2.59e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—COMT—prostate cancer	2.06e-06	2.59e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTP1—prostate cancer	2.05e-06	2.57e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GNG5—prostate cancer	2.05e-06	2.57e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ITPR1—prostate cancer	2.02e-06	2.53e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—RXRA—prostate cancer	2.02e-06	2.53e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NCOA3—prostate cancer	1.97e-06	2.47e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—COMT—prostate cancer	1.94e-06	2.44e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTP1—prostate cancer	1.94e-06	2.43e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TYMS—prostate cancer	1.91e-06	2.39e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ITPR1—prostate cancer	1.9e-06	2.39e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTM1—prostate cancer	1.89e-06	2.36e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HPGDS—prostate cancer	1.88e-06	2.36e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.87e-06	2.34e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—LPL—prostate cancer	1.85e-06	2.32e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ACHE—prostate cancer	1.83e-06	2.29e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTT1—prostate cancer	1.83e-06	2.29e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.8e-06	2.26e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TYMS—prostate cancer	1.8e-06	2.25e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP1A1—prostate cancer	1.79e-06	2.24e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTM1—prostate cancer	1.78e-06	2.23e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ERCC2—prostate cancer	1.77e-06	2.22e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.76e-06	2.2e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PRKACB—prostate cancer	1.75e-06	2.19e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—LPL—prostate cancer	1.75e-06	2.19e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.73e-06	2.17e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.69e-06	2.11e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ERCC2—prostate cancer	1.67e-06	2.1e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MTHFR—prostate cancer	1.67e-06	2.09e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NCOA2—prostate cancer	1.65e-06	2.06e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PPARA—prostate cancer	1.64e-06	2.05e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MTHFR—prostate cancer	1.57e-06	1.97e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.57e-06	1.97e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PPARA—prostate cancer	1.54e-06	1.93e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CAV1—prostate cancer	1.54e-06	1.93e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.53e-06	1.92e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NQO1—prostate cancer	1.52e-06	1.9e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TH—prostate cancer	1.5e-06	1.87e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.45e-06	1.82e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CAV1—prostate cancer	1.45e-06	1.82e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GGT1—prostate cancer	1.41e-06	1.77e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CG—prostate cancer	1.4e-06	1.76e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.39e-06	1.74e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.37e-06	1.71e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—INS—prostate cancer	1.33e-06	1.66e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.32e-06	1.65e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—RXRA—prostate cancer	1.32e-06	1.65e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CREBBP—prostate cancer	1.3e-06	1.63e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—COMT—prostate cancer	1.27e-06	1.59e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.27e-06	1.59e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—INS—prostate cancer	1.25e-06	1.57e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.25e-06	1.56e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CD—prostate cancer	1.23e-06	1.54e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.22e-06	1.53e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TYMS—prostate cancer	1.18e-06	1.47e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NOS3—prostate cancer	1.16e-06	1.46e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.16e-06	1.46e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.16e-06	1.45e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—LPL—prostate cancer	1.14e-06	1.43e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.1e-06	1.38e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NOS3—prostate cancer	1.1e-06	1.37e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.09e-06	1.37e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CB—prostate cancer	1.07e-06	1.35e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTGS2—prostate cancer	1.06e-06	1.33e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.03e-06	1.29e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.01e-06	1.27e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PPARA—prostate cancer	1.01e-06	1.26e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTGS2—prostate cancer	1e-06	1.26e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CAV1—prostate cancer	9.48e-07	1.19e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTEN—prostate cancer	9.28e-07	1.16e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—EP300—prostate cancer	8.85e-07	1.11e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTEN—prostate cancer	8.75e-07	1.1e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CG—prostate cancer	8.64e-07	1.08e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—EP300—prostate cancer	8.34e-07	1.04e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—INS—prostate cancer	8.17e-07	1.02e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CREBBP—prostate cancer	8.01e-07	1e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CD—prostate cancer	7.59e-07	9.51e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NOS3—prostate cancer	7.17e-07	8.98e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CB—prostate cancer	6.62e-07	8.29e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTGS2—prostate cancer	6.56e-07	8.21e-06	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CA—prostate cancer	6.55e-07	8.2e-06	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CA—prostate cancer	6.17e-07	7.73e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTEN—prostate cancer	5.72e-07	7.16e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—EP300—prostate cancer	5.45e-07	6.83e-06	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AKT1—prostate cancer	5.35e-07	6.7e-06	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AKT1—prostate cancer	5.04e-07	6.31e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.03e-07	5.05e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AKT1—prostate cancer	3.3e-07	4.13e-06	CbGpPWpGaD
